Enanta Pharmaceuticals (ENTA) EBITDA Margin (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -862.00 |
| Dec 31, 2025 | 6,111.00 |
| Sep 30, 2025 | -1,840.00 |
| Jun 30, 2025 | 6,116.00 |
| Mar 31, 2025 | -2,550.00 |
| Dec 31, 2024 | 6,556.00 |
| Sep 30, 2024 | -6,980.00 |
| Jun 30, 2024 | 5,755.00 |
| Mar 31, 2024 | 165.00 |
| Dec 31, 2023 | -2,988.00 |
| Sep 30, 2023 | 3,043.00 |
| Jun 30, 2023 | 2,737.00 |
| Mar 31, 2023 | -9,444.00 |
| Dec 31, 2022 | 588.00 |
| Sep 30, 2022 | 3,392.00 |
| Jun 30, 2022 | 1,379.00 |
| Mar 31, 2022 | -7,086.00 |
| Dec 31, 2021 | 3,308.00 |
| Sep 30, 2021 | 1,346.00 |
| Jun 30, 2021 | -900.00 |
| Mar 31, 2021 | -10,878.00 |
| Dec 31, 2020 | 4,497.00 |
| Sep 30, 2020 | 3,879.00 |
| Jun 30, 2020 | -7,952.00 |
| Mar 31, 2020 | -6,748.00 |
| Dec 31, 2019 | 1,195.00 |
| Sep 30, 2019 | 407.00 |
| Jun 30, 2019 | 1,175.00 |
| Mar 31, 2019 | -4,315.00 |
| Dec 31, 2018 | -1,140.00 |
| Sep 30, 2018 | 1,173.00 |
| Jun 30, 2018 | 126.00 |
| Mar 31, 2018 | 55.00 |
| Dec 31, 2017 | -3,378.00 |
| Sep 30, 2017 | 24,631.00 |
| Jun 30, 2017 | -6,869.00 |
| Mar 31, 2017 | -3,847.00 |
| Dec 31, 2016 | -4,351.00 |
| Sep 30, 2016 | -1,634.00 |
| Jun 30, 2016 | -345.00 |
| Mar 31, 2016 | -7,782.00 |
| Dec 31, 2015 | 4,799.00 |
| Sep 30, 2015 | 1,080.00 |
| Jun 30, 2015 | -6,997.00 |
| Mar 31, 2015 | -595.00 |
| Dec 31, 2014 | 29,257.00 |
| Sep 30, 2014 | -28,495.00 |
| Jun 30, 2014 | 32,034.00 |
| Mar 31, 2014 | 37,373.00 |
| Dec 31, 2013 | -26,261.00 |
| Sep 30, 2013 | -9,511.00 |
| Jun 30, 2013 | 8,117.00 |
| Mar 31, 2013 | -41,317.00 |
| Dec 31, 2012 | 29,909.00 |
| Sep 30, 2012 | -8,166.00 |
| Jun 30, 2012 | -22,656.00 |